NEWPORT BEACH, Calif. - (Business Wire) Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, has announced that 35 early- to late-stage medical technology companies seeking funding and/or strategic partnership are confirmed to date as presenters at its "Investment In Innovation (In3) Medical Device Summit," June 17-19, 2008 at The Palace Hotel in San Francisco, California. The In3 Summit, the company
’s largest strategic partnership and investment conference for medical technology executives, the is the most important venue of its kind for previewing cutting-edge emerging medtech companies and engaging with the biggest dealmakers in the industry, including senior executives from the device industry and healthcare investment community, all in a short amount of time.
Conference highlights will include presentations by more than 60 early- to late-stage medical technology companies in all, focused into 3 concurrent tracks, each followed by break-out sessions in private conference rooms. The 3 tracks will consist of 1) Cardiovascular and peripheral vascular companies, 2) Orthopedics and spine companies, and 3) Other high-growth technology areas such as device coatings/infection control, diabetes management, diagnostics, endoscopic technology , incontinence products, oncology diagnostics and therapeutics, ophthalmic surgery, and reproduction management, among others.
Track 1 (Cardio/Peripheral Vascular) presenters to date include Arterial Remodeling Technologies, CardiAQ Valve Technologies, Emergence Life Science Incubator, ES Vascular Ltd., Genesis Medical Interventional, Neochord, Inc., PreMD Inc., PROTOMED, Tayside Flow Technologies Limited, Thornhill Research Inc., and Tissue Genetics. Track 2 (Ortho/Spine) presenters confirmed to date include Bone Biologics, Inc., Emergence Life Science Incubator, Innova Orthopaedics, Ortho Kinematics, Orthovita, Inc., and Vertebration, Inc. Track 3 (Other High-Growth Technologies) presenting companies to date include Altascience Limited, Ceragenix Pharmaceuticals, CVAC Systems, Inc., EyeGate Pharmaceuticals, Inc., Gel Delivery Solutions BV, GlucoLight Corporation, Healionics Corporation, InfraScan, Inc., Keraderm LLC, MicroPhage, Inc., MoleMap, Nanobiotix, Novian Health Inc., Photo Dynamic Therapy, Polymedix, Softscope Medical Technologies, Vasorum Ltd., Vironova AB, and Zassi Medical Evolutions Inc. Visit the In3 Summit website at www.meddevicesummit.com for the latest event updates.
The In3 Summit’s growing attendee list includes a robust line-up of buy-side/investors from around the world. A sample of companies sending their teams include: Accuitive Medical Ventures, Aubrey Group, Inc., Becton Dickinson, BioQuest, Boston Biomedical Associates, Cardinal Health, Cook Group, Inc., Coronis Medical Ventures, Covidien, Delphi Ventures, Dow Europe, DuPont BioSciences, Easton Associates, Emergent Medical Ventures, Essex Woodlands Venture Partners, Ethicon Endo-Surgery, Inc., F-D-C Reports, Inc., FMR Group, Foster-Miller, Inc., Frazier Healthcare Ventures, HLM Venture Partners, Invest In Germany, Johnson & Johnson, Kaiser Permanente Ventures, MachVentures, LLC, Matignon Technologies FCPR, Mayo Clinic Health Solutions, Medical Device Consultants, Inc., Medical Leaders Company, Ltd., MedicineLodge, Inc., MPM Capital, Musculoskeletal Transplant Foundation, Nippon Sigmax Company, Ltd., PFM, Prism Venture Partners, Prospect Venture Partners, RBC Product Development, Scale Venture Partners, Sorin Group, Spectranetics, St. Jude Medical, Stryker, Synectic Engineering, Inc., Teijin America, Teijin Pharma, Ltd., York Medtech Partners, and Ziegler Meditech Equity Partners.
The Summit will kick off with a Pre-Conference Workshop hosted by Chris Velis of Medical Capital Advisors, entitled “Top 10 Tips for Planning your VC Funding and Exit,” followed by an insightful State of the Device Industry Address by David Cassak, titled “A Market Analysis of Where Medical Technology Companies are Going.” Also on the program on June 18th is an informative and interactive Panel Discussion entitled “How Large Companies Sustain Growth through M&A and Strategic Partnerships,” with panelists to include Richard Dakers, VP, Franchise Development, Cordis, a Johnson & Johnson Company; Stanton Rowe, Corporate VP for Advanced Technologies, Edwards Lifesciences; and Matthew Jennings, Senior Vice President, Corporate Development, Teleflex.
A Venture Capital Perspective Panel Discussion is also featured on the program on the first full day of the meeting, entitled “Early Stage Investing, Financing and Exit Strategies,” moderated by Steve Levin, Executive Editor at Windhover Information, with panelists to include Trevor J. Moody, Partner, Frazier Healthcare Ventures; John Maroney, General Partner, Delphi Ventures; Luke Evnin, General Partner, MPM Capital; and John Lonergan, Partner, Mach Ventures, LP. The first day is concluded with a Presenting Company Product Exhibition/Networking Reception.
On Thursday morning the 19th, a highly anticipated Emerging Markets for Medical Devices Panel Discussion will take place, titled “Mining China for Potential Investments,” with panelists to include Immanuel Thangaraj, Managing Director, Essex Woodland Health Ventures; Dr. Nancy Chang, Managing Director, OrbiMed; Carin Fradin, Executive Director, Global Healthcare Group, UBS; and Michael Yi Zhang, Ph.D., Chairman, Otsuka (China) Investment Co. Ltd. The exceptional In3 Summit program will also feature two educational Workshops for start-up companies, one entitled “Creating Effective Presentations: Tips for Developing, Honing and Enhancing Your Presentation Skills and Content Development,” hosted by Standing Stone Partners, and the other, “The Impact of Recent Patent Infringement Decisions and Litigation Outcomes on Your Medical Device Company,” hosted by Knobbe Martens.
In3 Summit co-sponsors include the AdvaMed Emerging Growth Company Council (EGCC), Battelle, Business Wire, Knobbe Martens, MDMA, Medmarc and The Hartford, Medical Capital Advisors, The MedTech Group, Ronald Trahan Associates, Summit Corporate Services, and F-D-C Reports’ The Gray Sheet.
Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1350 emerging medical technology company presenters and over 7200 attendees have participated at In3 events over the past 7 years.
Medtech Insight and Windhover Information will also be holding their annual “In3 East” conference at the Westin Copley Place October 22-24 in Boston, MA. For more information on this event, in addition to other industry shows where the company will be exhibiting, please call Medtech Insight or visit the company's website at www.medtechinsight.com.
About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please visit www.medtechinsight.com.
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.
kristy@medtechinsight.com
www.meddevicesummit.com
